Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum’s Disease Treatment
– CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum’s disease treatment. – CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum’s disease treatment earlier this year. – CBL-514 Phase 2 study for
CALL FOR ENTRIES – 2025 CANADIAN HILLMAN PRIZES FOR JOURNALISM
* ATTENTION JOURNALISTS, EDITORS AND AWARDS COORDINATORS * DEADLINE: JANUARY 15, 2025 Annual prizes honour excellence in journalism in service of the common good TORONTO, Nov. 12, 2024 /CNW/ – The Sidney Hillman Foundation is now accepting nominations for the 2025 Canadian Hillman Prizes, hon
A Decade of League: 10 Years of Transforming Healthcare at Scale
Healthcare CX platform leader announces 25 million user milestone and industry-leading growth of 158% compound annual growth rate TORONTO, Nov. 12, 2024 /PRNewswire/ – League, the leading healthcare consumer experience (CX) platform serving over 25 million users, is celebrating its 10th anni
Corporate Technologies enters its 17th market with the acquisition of RSPN in Iowa
EDEN PRAIRIE, Minn., Nov. 12, 2024 /PRNewswire/ — Corporate Technologies, a leading national managed service provider (MSP) offering IT and cybersecurity solutions, has acquired RSPN, an MSP serving SMB customers in the Cedar Falls and Waterloo region of Iowa. The acquisition expands Corpor
Digital Finance Research Institute: Charles Brown’s New AI System Offers Intelligent Solutions for Dynamic Market Conditions
CHICAGO, Nov. 12, 2024 /PRNewswire/ — Digital Finance Research Institute has launched its new AI-powered Smart Investment Decision System, marking a pivotal advancement in quantitative trading technology. This system leverages deep learning, big data analytics, and machine learning to analyze
Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing
Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for the global Antibody-Drug Conjugate (ADC) industry. Chime Biologics will leverage its CMC expertise in biologics to manage Antibody Intermediate, ADC Drug Substance and Drug Product, wh
The Beltone Hearing Care Foundation Celebrates 10 Years of Empowering Ears with ‘Hear for the Holidays’ Hearing Aid Giveaway
Named by Newsweek as one of America’s Best of the Best in Hearing Care for 2024, Beltone continues its dedication to patients by giving away a set of hearing aids each day in December through its charitable foundation. CHICAGO, Nov. 12, 2024 /PRNewswire/ — The Beltone Hearing Care Found
Rural King Opens its Second Georgia Store This Year in Waycross
MATTOON, Ill., Nov. 12, 2024 /PRNewswire/ — Rural King, a family-owned retailer dedicated to the rural lifestyle, is excited to announce that its newest store in Waycross, GA, its sixth new store this year, is now open. Grand opening festivities will take place from Friday, November 15 through
WellNow Urgent Care Announces Return to Excellus BlueCross BlueShield Network
Excellus BCBS insurance will be accepted at WellNow Urgent Care effective November 15 EAST SYRACUSE, N.Y., Nov. 12, 2024 /PRNewswire/ — WellNow Urgent Care announced today that it has reached a definitive agreement to return to the Excellus BlueCross BlueShield insurance network. Excellus BCBS
Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance
Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million – $43 million ZYNRELEF® (bupivacaine and meloxicam) extended-release solution Vial Access Needle (“VAN”) approved in September and on track for Q4 2024 launch
